Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|31|4807-4822

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.31, 2016-09, pp. : 4807-4822

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets

By  

Current Pharmaceutical Design, Vol. 22, Iss. 31, 2016-09 ,pp. : 4752-4762

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic Heart Failure: Current Evidence, Challenges to Therapy, and Future Directions

By Morrissey Ryan P.   Czer Lawrence   Shah Prediman K.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 3, 2011-06 ,pp. : 153-171

Adis International

Access to resources Recommend Favorite

Nebivolol in chronic heart failure: current evidence and future perspectives

By Lipšic Erik   van Veldhuisen Dirk J  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 983-992

Informa Healthcare

Access to resources Recommend Favorite

Blood Coagulation in Patients with Chronic Heart Failure: Evidence for Hypercoagulable State and Potential for Pharmacological Intervention

By De Lorenzo F.   Saba N.   Kakkar V.V.  

Drugs, Vol. 63, Iss. 6, 2003-01 ,pp. : 565-576

Adis International

Access to resources Recommend Favorite

Potential Mechanisms of Benefit with Thalidomide in Chronic Heart Failure

By Aukrust Pål   Yndestad Arne  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 2, 2007-01 ,pp. : 127-134

Adis International

Access to resources Recommend Favorite